Table 3.
Involved organs at disease onset and at the last follow-up, and the mortality rates
| Onset | Mortality rates (Death) | Last follow-up | Mortality rates (Death) |
|---|---|---|---|
| AO, 135 patients | 5.9% (8)a | ALb, 91 patients | 3.3% (3) |
| BLb, 44 patients | 11% (5) | ||
| RO, 48 patients | 15% (7) | RL, 39 patients | 13% (5) |
| BLb, 9 patients | 22% (2) | ||
| MO, 46 patients | 15% (7)a | AL, 26 patients | 19% (5) |
| RL, 8 patients | 0% (0) | ||
| BL, 12 patients | 17% (2) |
aMortality rate was significantly higher in MO patients than that in AO patients (P = 0.048). bAL: patients with auricular without respiratory involvement at the last follow-up (Auricular-Last), RL: patients with respiratory without auricular involvement at the last follow-up (Respiratory-Last), BL: patients with both respiratory and auricular involvement at the last follow-up (Both-Last). MO patients demonstrated poor prognosis even without respiratory involvement, namely 26 MO-AL patients, at the last follow-up